By integrating evidence across cardiovascular, renal, pulmonary, digestive, neurological, and autoimmune diseases, we delineate the underappreciated contribution of non-PRRs triggers—including STING mutations, ER stress, and trafficking or degradation defects—that remain overlooked in the current literature. The gene discussed is STING1; the disease is autoimmune disease.